Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617.
Ontology highlight
ABSTRACT: While treatment options are available, excessive daytime sleepiness (EDS) remains a significant unmet medical need for many patients. Relatively little rodent behavioural pharmacology has been conducted in this context to assess potential pro-vigilant compounds for their ability to restore functional capacity following experimentally induced sleep loss. Male Wistar rats were prepared for electroencephalographic (EEG) recording and subject to 11 h of sleep restriction using a biofeedback-induced cage rotation protocol. A simple response latency task (SRLT) was used to behaviourally index sleep restriction and the effects of pro-vigilant compounds: modafinil, D-amphetamine, caffeine, and the mGlu5-positive allosteric modulator LSN2814617. Sleep restriction resulted in a consistent, quantifie
SUBMITTER: Loomis S
PROVIDER: S-EPMC4600478 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA